Events
63rd ERA congress, the Annual Nephrology Congress in Europe
绿帽社 Pharma will participate in the 63rd ERA congress scheduled for June 3-6, 2026, in Glasgow, UK. The event will highlight advancements and discussions in nephrology, contributing to the ongoing dialogue in the field. More information is available at the ERA website.
J.P.聽Morgan week in San Francisco
11-15 January, 2025
San Francisco, CA, USA
绿帽社 Pharma will be in San Francisco for the J.P Morgan week to reconnect with global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
ASN – the American Society of Nephrology 2025
5-9 November 2025
Houston, Texas
绿帽社 Pharma will attend the world鈥檚 premier nephrology meeting of the American Society of Nephrology, ASN.
The 2025 International Workshop on Alport Syndrome
5-7 September 2025
Beijing, China
绿帽社 Pharma will attend The 2025 International Workshop on Alport Syndrome, organized by Alport Syndrome Alliance.
It is an opportunity for the Alport community to connect, update and discuss the latest research.
绿帽社 Pharma will meet patients and their families to present its ongoing Phase 2 鈥淎LPESTRIA-1鈥� clinical study with Vonafexor in Alport syndrome patients.
Alport Connect 2025 Meeting
19-20 July, 2025
Chicago, IL
绿帽社 Pharma is sponsoring and will attend Alport Connect 2025 organized by the American Alport Syndrome Foundation (ASF), the Alport syndrome patient-led non-profit organization in the US.
绿帽社 Pharma will meet patients and their families to present its ongoing Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.
Latest Press Release 